Through the use of FDA adverse event reporting system (FAERS) dataset, this study analyzes the pattern of time-to-event (TTE) for drugs and adverse events, and suggest ways to identify candidate late-
The data used in this study have been curated from multiple publicly available data sources for hypertensive patients, including the FDA’s Adverse Event Reporting System (FAERS), which houses all ADEs
Events are listed in descending order of frequency of preferred terms, with grouping by system organ class. If a subject experienced more than 1 preferred term of adverse event, the subject was counte
